Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;10(7):2083-8.
doi: 10.4161/hv.28698.

Premature B-cell senescence as a consequence of chronic immune activation

Affiliations
Review

Premature B-cell senescence as a consequence of chronic immune activation

Paolo Palma et al. Hum Vaccin Immunother. 2014.

Abstract

Similar features between the immune system of healthy elderly people and of younger individuals subjected to conditions of chronic immune activation are progressively being observed. This is raising the hypothesis that chronic immune activation may cause the premature aging of the immune system. Here we dissect this theory by comparing changes occurring to B-cells during healthy aging to the ones occurring during chronic immune activation in younger individuals. Moreover, we discuss how these changes may affect or predict response to vaccination in immune compromised individuals.

Keywords: activation-induced deaminase (AID); aging; double negative B-cells; immunization; immunosenescence; inflammaging; mature-activated B-cells; predictive biomarkers.

PubMed Disclaimer

Figures

None
Figure 1. (A) DN B-cells may be late or exhausted memory B-cells which have lost the expression of CD27 carrying a decreased number of SHMs in the Ig V region. However, a low number of SHM should not be expected in this population as SHMs would accumulate at each cell division in pre-established memory B-cells during specific recall or bystander activation. (B) DN B-cells may be naïve B-cells being triggered by polyclonal stimuli due to increased circulation of microbial products between body compartments due to damaged and inflamed tissue. In this scenario, CD27-IgD+ naïve B-cells would switch to CD27-IgD- B-cells.

References

    1. Sagaert X, De Wolf-Peeters C. Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage. Immunol Lett. 2003;90:179–86. doi: 10.1016/j.imlet.2003.09.007. - DOI - PubMed
    1. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood. 2002;99:3892–904. doi: 10.1182/blood.V99.11.3892. - DOI - PubMed
    1. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179–91. doi: 10.1111/j.0105-2896.2004.0109.x. - DOI - PubMed
    1. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32:129–40. doi: 10.1016/j.immuni.2009.11.009. - DOI - PubMed
    1. Buffa S, Pellicano M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G. A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr). 2013;35:2009–24. - PMC - PubMed

LinkOut - more resources